Follow
Brian Dean
Title
Cited by
Cited by
Year
Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors
M Berk, F Kapczinski, AC Andreazza, OM Dean, F Giorlando, M Maes, ...
Neuroscience & biobehavioral reviews 35 (3), 804-817, 2011
11702011
Studies on [3H] CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use
B Dean, S Sundram, R Bradbury, E Scarr, D Copolov
Neuroscience 103 (1), 9-15, 2001
4952001
Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia
XM Gao, K Sakai, RC Roberts, RR Conley, B Dean, CA Tamminga
American Journal of Psychiatry, 2000
4752000
Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between …
A Knafo, S Israel, A Darvasi, R Bachner‐Melman, F Uzefovsky, L Cohen, ...
Genes, brain and behavior 7 (3), 266-275, 2008
3822008
Towards a muscarinic hypothesis of schizophrenia
TJ Raedler, FP Bymaster, R Tandon, D Copolov, B Dean
Molecular psychiatry 12 (3), 232-246, 2007
3172007
Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation
JM Crook, E Tomaskovic-Crook, DL Copolov, B Dean
Biological psychiatry 48 (5), 381-388, 2000
2572000
Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology
A Fornito, M Yücel, B Dean, SJ Wood, C Pantelis
Schizophrenia bulletin 35 (5), 973-993, 2009
2552009
Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann’s areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment
JM Crook, E Tomaskovic-Crook, DL Copolov, B Dean
American Journal of Psychiatry, 2001
2372001
Molecular profiles of schizophrenia in the CNS at different stages of illness
S Narayan, B Tang, SR Head, TJ Gilmartin, JG Sutcliffe, B Dean, ...
Brain research 1239, 235-248, 2008
2122008
Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia
B Dean, M McLeod, D Keriakous, J McKenzie, E Scarr
Molecular psychiatry 7 (10), 1083-1091, 2002
2052002
Increase in remission rate in newly diagnosed type I diabetic subjects treated with azathioprine
LC Harrison, PG Colman, B Dean, R Baxter, FIR Martin
Diabetes 34 (12), 1306-1308, 1985
1831985
Changes in Serotonin2A and GABAA Receptors in Schizophrenia: Studies on the Human Dorsolateral Prefrontal Cortex
B Dean, T Hussain, W Hayes, E Scarr, S Kitsoulis, C Hill, K Opeskin, ...
Journal of neurochemistry 72 (4), 1593-1599, 1999
1801999
A role for estrogen in schizophrenia: clinical and preclinical findings
A Gogos, AM Sbisa, J Sun, A Gibbons, M Udawela, B Dean
International journal of endocrinology 2015, 2015
1742015
Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder
RE McCullumsmith, LV Kristiansen, M Beneyto, E Scarr, B Dean, ...
Brain research 1127, 108-118, 2007
1722007
Autophagy has a key role in the pathophysiology of schizophrenia
A Merenlender-Wagner, A Malishkevich, Z Shemer, M Udawela, ...
Molecular psychiatry 20 (1), 126-132, 2015
1652015
The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia.
B Dean, JM Crook, K Opeskin, C Hill, N Keks, DL Copolov
Molecular psychiatry 1 (1), 54-58, 1996
1641996
Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia
A Torkamani, B Dean, NJ Schork, EA Thomas
Genome research 20 (4), 403-412, 2010
1552010
Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation
N Nakatani, E Hattori, T Ohnishi, B Dean, Y Iwayama, I Matsumoto, T Kato, ...
Human molecular genetics 15 (12), 1949-1962, 2006
1472006
Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders
EA Thomas, B Dean, G Pavey, JG Sutcliffe
Proceedings of the National Academy of Sciences 98 (7), 4066-4071, 2001
1472001
Phospholipase C-β1 knockout mice exhibit endophenotypes modeling schizophrenia which are rescued by environmental enrichment and clozapine administration
CE McOmish, E Burrows, M Howard, E Scarr, D Kim, HS Shin, B Dean, ...
Molecular psychiatry 13 (7), 661-672, 2008
1452008
The system can't perform the operation now. Try again later.
Articles 1–20